Caplacizumab (an anti-von Willebrand Factor Nanobody) ( DrugBank: Caplacizumab, Von willebrand factor )

1 disease
IDDisease name (Link within this page)Number of trials
64Thrombotic thrombocytopenic purpura6

64. Thrombotic thrombocytopenic purpura

Clinical trials : 92 / Drugs : 85 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 76 
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries